Switching from oral extended-release methylphenidate to the methylphenidate transdermal system: continued attention-deficit/hyperactivity disorder symptom control and tolerability after abrupt conversion.

Source:http://linkedlifedata.com/resource/pubmed/id/19916704

Download in:

View as

General Info

PMID
19916704